AC Immune SA revenue for the last year amounted to 30.07 M USD, the most of which — 31.01 M USD — came from its highest performing source at the moment, Therapeutic and Diagnostic Products, the year earlier bringing 16.47 M USD. The greatest contribution to the revenue figure was made by Switzerland — last year it brought AC Immune SA 31.01 M USD, and the year before that — 16.47 M USD.